122 related articles for article (PubMed ID: 10953987)
21. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.
Wang Y; Hopwood VL; Hu P; Lennon A; Osterberger J; Glassman A
Cancer Genet Cytogenet; 2004 Aug; 153(1):53-6. PubMed ID: 15325094
[TBL] [Abstract][Full Text] [Related]
22. [Acquisition of Philadelphia chromosome with bcr rearrangement concomitant with transformation of refractory anemia with excess of blasts with 8 trisomy into acute myelogenous leukemia].
Niikura H; Fujita K; Terada H; Haga A; Yamashina A
Rinsho Ketsueki; 1990 Mar; 31(3):335-40. PubMed ID: 2366338
[TBL] [Abstract][Full Text] [Related]
23. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8.
Andersen MK; Pedersen-Bjergaard J; Kjeldsen L; Dufva IH; Brøndum-Nielsen K
Leukemia; 2002 Jul; 16(7):1390-3. PubMed ID: 12094265
[No Abstract] [Full Text] [Related]
24. [Chromosomal abnormalities in 38 CML cases of various phases].
Su XY; Cao Q; He KL
Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):34-7. PubMed ID: 11601004
[TBL] [Abstract][Full Text] [Related]
25. Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.
Orciuolo E; Buda G; Galimberti S; Sordi E; Cervetti G; Petrini M
Cancer Genet Cytogenet; 2007 Sep; 177(2):166-7. PubMed ID: 17854678
[No Abstract] [Full Text] [Related]
26. Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression.
Najfeld V; Wisch N; Mascarenhas J; Issa L; Tripodi J; Sidhu M; Hoffman R
Cancer Genet; 2011 Mar; 204(3):165-70. PubMed ID: 21504717
[TBL] [Abstract][Full Text] [Related]
27. Philadelphia negative BCR-ABL positive chronic myeloid leukemia mimicking juvenile chronic myeloid leukemia in a 2-year-old child.
Mahon FX; Labouyrie E; Aurich-Costa J; Dastugue N; Micheau M; Bady C; Perel Y; Bilhou-Nabera C; Reiffers J; Bernard P
Leuk Lymphoma; 1997 Aug; 26(5-6):615-9. PubMed ID: 9389369
[TBL] [Abstract][Full Text] [Related]
28. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
29. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
30. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
[TBL] [Abstract][Full Text] [Related]
31. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
32. Unusual clonal evolution during blast crisis of chronic myeloid leukaemia (CML).
Christodoulidou F; Silver RT; Macera MJ; Verma RS
Eur J Cancer; 1994; 30A(7):1040-1. PubMed ID: 7946570
[No Abstract] [Full Text] [Related]
33. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
35. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
[TBL] [Abstract][Full Text] [Related]
36. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biological aspects of Philadelphia-negative/BCR-negative chronic myeloid leukemia.
Costello R; Sainty D; Lafage-Pochitaloff M; Gabert J
Leuk Lymphoma; 1997 Apr; 25(3-4):225-32. PubMed ID: 9168433
[TBL] [Abstract][Full Text] [Related]
38. Haematological differences between chronic granulocytic leukaemia, atypical chronic myeloid leukaemia, and chronic myelomonocytic leukaemia.
Galton DA
Leuk Lymphoma; 1992 Aug; 7(5-6):343-50. PubMed ID: 1493435
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
[TBL] [Abstract][Full Text] [Related]
40. Clonal evolution in Ph-negative, bcr-positive chronic myeloid leukaemia before and after bone marrow transplantation.
Secker-Walker LM; Cooke HM; Browett PJ; Norton JD; Kitchen C; Prentice AG; Prentice HG
Acta Haematol; 1989; 82(4):205-9. PubMed ID: 2511723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]